These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14684768)

  • 1. Editorial comment--stroke cost-effectiveness research: are acceptability curves acceptable?
    Holloway R; Dick AW
    Stroke; 2004 Jan; 35(1):203-4. PubMed ID: 14684768
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternative strategies for stroke care: cost-effectiveness and cost-utility analyses from a prospective randomized controlled trial.
    Patel A; Knapp M; Perez I; Evans A; Kalra L
    Stroke; 2004 Jan; 35(1):196-203. PubMed ID: 14684783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Training care givers of stroke patients: economic evaluation.
    Patel A; Knapp M; Evans A; Perez I; Kalra L
    BMJ; 2004 May; 328(7448):1102. PubMed ID: 15130978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New horizons in stroke rehabilitation research.
    Hoenig H; Horner RD; Duncan PW; Clipp E; Hamilton B
    J Rehabil Res Dev; 1999 Jan; 36(1):19-31. PubMed ID: 10659891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economics in epilepsy treatment choices: our certain fate?
    Heaney DC; Beran RG; Halpern MT
    Epilepsia; 2002; 43 Suppl 4():32-8. PubMed ID: 12059999
    [No Abstract]   [Full Text] [Related]  

  • 6. Examining the cost per caregiver of an intervention designed to improve the quality of life of spousal caregivers of stroke survivors.
    Parker EK; Swint JM; Godwin KM; Ostwald SK
    Rehabil Nurs; 2012; 37(5):244-51. PubMed ID: 22949277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accounting for the missing opportunity costs in incremental cost-outcome analysis.
    Oliver A
    Appl Health Econ Health Policy; 2002; 1(4):191-6. PubMed ID: 14619248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations of the Second Panel on Cost Effectiveness in Health and Medicine: A Reference, Not a Rule Book.
    Carias C; Chesson HW; Grosse SD; Li R; Meltzer MI; Miller GF; Murphy LB; Nurmagambetov TA; Pike JJ; Whitham HK
    Am J Prev Med; 2018 Apr; 54(4):600-602. PubMed ID: 29338958
    [No Abstract]   [Full Text] [Related]  

  • 9. A prospective study on coping strategies and quality of life in patients after stroke, assessing prognostic relationships and estimates of cost-effectiveness.
    Darlington AS; Dippel DW; Ribbers GM; van Balen R; Passchier J; Busschbach JJ
    J Rehabil Med; 2009 Mar; 41(4):237-41. PubMed ID: 19247542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unintended consequences of applying economic evaluation.
    Oliver A
    J Health Serv Res Policy; 2002 Jul; 7(3):129-30. PubMed ID: 12171741
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost, effectiveness, and cost-effectiveness.
    Diamond GA; Kaul S
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):49-54. PubMed ID: 20031812
    [No Abstract]   [Full Text] [Related]  

  • 12. Analytic approaches for the evaluation of costs.
    Glick HA; Polsky D
    Hepatology; 1999 Jun; 29(6 Suppl):18S-22S. PubMed ID: 10386078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accounting for future costs in medical cost-effectiveness analysis.
    Meltzer D
    J Health Econ; 1997 Feb; 16(1):33-64. PubMed ID: 10167344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of antenatal anti-D prophylaxis.
    Vick S; Cairns J; Urbaniak S; Whitfield C; Raafat A
    Health Econ; 1996; 5(4):319-28. PubMed ID: 8880168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The limits of cost-effectiveness analysis.
    Weintraub WS; Cohen DJ
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):55-8. PubMed ID: 20031813
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic considerations for the hepatologist.
    Provenzale D
    Hepatology; 1999 Jun; 29(6 Suppl):13S-17S. PubMed ID: 10386077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic foundations of cost-effectiveness analysis.
    Garber AM; Phelps CE
    J Health Econ; 1997 Feb; 16(1):1-31. PubMed ID: 10167341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How much are health-care systems prepared to pay to produce a QALY?
    Buxton MJ
    Eur J Health Econ; 2005 Dec; 6(4):285-7. PubMed ID: 16258748
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic and Societal Aspects of Stroke Management.
    Mukundan G; Seidenwurm DJ
    Neuroimaging Clin N Am; 2018 Nov; 28(4):683-689. PubMed ID: 30322602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness Analysis 2.0.
    Neumann PJ; Sanders GD
    N Engl J Med; 2017 Jan; 376(3):203-205. PubMed ID: 28099837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.